Ways to increase patient compliance in the drugs preferential provision

Compliance of patients in the drugs preferential provision is considered as the most important component of effectiveness and safety pharmacotherapy.

Aim. Based on the study of patient compliance in the drugs preferential provision program to develop recommendations and proposals to improve adherence to treatment.

Materials and methods. A sociological survey was conducted at 115 patients suffering from chronic diseases in four polyclinics in Vladivostok in 2019. All patients were treated under the «Program of Providing Certain Categories of Citizens with Necessary Drugs». The study used descriptive statistics methods using the Microsoft Office program.

Results. The highest level of adherence was noted in the indicators «compliance with the recommendations of the attending physician for taking medicines» — 78.3 % and «absence of a pass in taking medicines» — 76.5 %. The greatest compliance to drugs treatment (< 50 %) on the majority of indicators of questioning is registered at patients with diagnoses: «diabetes mellitus», «bronchial asthma» and «malignant neoplasms», and also at co-morbid patients. The lowest adherence to pharmacotherapy (> 50 %) was in groups of patients with hypertension and chronic renal failure. Compliance in the field of non-drugs treatment is not sufficient.

Conclusion. The sociological survey showed that adherence to medication and non-medication treatment is insufficient. To improve the compliance it is recommended the introduction of programs of patient education with use of modern interactive educational technologies.

1. Prjamaja linija s Vladimirom Putinym 20 ijunja 2019 goda. Доступно по: http://kremlin.ru/events/president/news/60795. (In Russ). Ссылка активна на 03.12.2019.

2. Khabriev RU, Sukhodolov AP, Spasennikov BA, et al. The decision-making system in the Program of Subsidized Pharmaceutical Provision. Remedium. 2018;28(1):6-11. (In Russ). DOI: 10.17150/2500-2759.2018.28

3. Volkova NS., Eremina OJu. Lekarstvennoe obespechenie invalidov: teoreticheskie i prakticheskie problemy. Zhurnal rossijskogo prava. 2018;11:85-96. (In Russ). DOI: 10.12737/art_2018_11_8

4. Stakhovskaya LV., Ivanova GE, Repyev AP. Medical law and the legal basis of medical rehabilitation. Pacific Medical Journal. 2015;1:30-34. (In Russ).

5. Jurgel’ NV, Tel’nova EA. DLO-ONLS, «7 nozologij», a chto dal’she? Vestnik Roszdravnadzora. 2008;5:4-21. (In Russ).

6. Tel’nova EA Programme DLO-ONLS 10 let. Vestnik Roszdravnadzora. 2016;5:143-147. (In Russ).

7. Oprosnik «Uroven’ komplaentnosti». Ed by Kadyrov R. V., Asrijan O. B., Koval’chuk S. A. Vladivostok: Izdatel’stvo Morskogo gosudarstvennogo universiteta; 2014. (In Russ).

8. Medvedev DA. Konstitucii: balans mezhdu svobodoj i otvetstvennost’ju. (In Russ). Доступно по: http://government.ru/news/35053/. Ссылка активна на 03.12.2019.

9. Russian Federation Constitution. (In Russ). Доступно по: http://www.constitution.ru/10003000/10003000-4.htm. Ссылка активна на 03.12.2019.

10. Federal Law of Russian Federation №323-F3 of 21 November 2011. «Ob osnovakh okhrany zdorov’ya grazhdan Rossiiskoi Federatsii». (In Russ). Доступно по: http://www.rosminzdrav.ru/documents/7025-federalnyy-zakon-323-fz-ot-21-noyabrya-2011-g. Ссылка активна на 03.12.2019.

11. World Health Organization: Adherence to long-term therapies. Evidence for action. World Health Organization 2003. Доступно по: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Ссылка активна на 03.12.2019.

12. Vol’skaja EA. Pacientskij komplaens. Obzor tendencij v issledovanijah. Remedium. 2013;(7):6-14. (In Russ).

13. Danilov DS. Terapevticheskoe sotrudnichestvo (komplaens): soderzhanie ponjatija, mehanizmy formirovanija i metody optimizacii. Nevrologija, nejropsihiatrija, psihosomatika. 2014;2:4-12. (In Russ). DOI: 10.14412/2074-2711-2014-2-4-12

14. Romanenko TS. Lechenie arterial’noj gipertonii v ambulatorno-poliklinicheskih uslovijah: preemstvennost’ terapii, priverzhennost’ lecheniju i farmakojekonomicheskie aspekty. [dissertation] Moscow; 2016 (In Russ). Доступно по: https://www.gnicpm.ru/data/files/dictionary/1547/111/Dissertation_RomanenkoTV.pdf. Ссылка активна на 03.12.2019.

15. Ignatenko GA, Muhin IV, Gavriljak VG, et al. Komplaentnost’ u bol’nyh komorbidnoj kardial’noj patologiej pri dlitel’nom periode nabljudenija. Vestnik neotlozhnoj i vosstanovitel’noj hirurgii. 2018;3(2):138-143. (In Russ).

16. Settineri S, Frisone F, Merlo EM, et al. Compliance, adherence, concordance, empowerment, and self-management: five words to manifest a relational maladjustment in diabetes. Journal of Multidisciplinary Healthcare. 2019;12:299-314.

17. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Medical Journal. 2011;26(3):155-159.

18. Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Medicine and Pharmacy Reports. 2019;92(2):117-122.

19. Beyhaghi H, Reeve BB, Rodgers JE, Stearns SC. Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants. Value Health 2016;19(8):996-1001.

20. Lukina YV, Martsevich SY, Kutishenko NP. The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes. Rational Pharmacotherapy in Cardiology. 2016;12(1):63-65 (In Russ).

21. Sorokin MY, Lutova NB, Wied VD. A role of motivation for treatment in the structure of compliance in psychopharmacologically treated patients. Journal of Neurology and Psychiatry. 2016;(4):32-36. (In Russ). DOI: 10.17116/jnevro20161164132-36.

22. Nikolayev NA, Skirdenko UP, Zherebilov VV. Quantitative assessment of adherence to treatment in clinical medicine: protocol, procedure, interpretation. Kachestvennaya klinicheskaya praktika. 2016;1:50-58. (In Russ).

23. Khaletskaya AI. Quality of life and level of adherence to therapy in comorbid patients with chronic obstructive pulmonary disease and chronic heart Failure. The Journal of scientific articles «Health and Education Millennium». 2018;20(3):61-65. (In Russ). DOI: 10.26787/nydha-2226-7425-2018-20-3

24. Sorokina AO. Komplaens pacientov s gipertonicheskoj bolezn’ju. Ustojchivoe razvitie nauki i obrazovanija. 2018;5:102-107. (In Russ).

25. Kleinsinger F. The Unmet Challenge of Medication Nonadherence. The Permanente Journal. 2018;22:18-033. DOI: 10.7812/TPP/18-033

26. Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. Journal of Public Health. 2018;(41):e84—e94. DOI: 10.1093/pubmed/fdy088

27. George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Preference and Adherence. 2019;13:1325-1334. DOI: 10.2147/PPA.S209532

28. Khunti K, Seidu S, Kunutsor S, Davies M. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Metaanalysis. Diabetes Care. 2017;40:1588-1586. DOI: 10.2337/dc16-1925

29. Bouwman L, Eeltink CM, Visser O, et al. Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation. BMC Cancer. 2017;17:739. DOI: 10.1186/s12885-017-3735-1

30. Steinkamp JM, Goldblatt N, Borodovsky JT, et al. Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review. JMIR Mental Health. 2019;6(3):e12493. DOI: 10.2196/12493:10.2196/12493

31. Spaan P, Luenen S, Garnefski N, Kraaij V. Psychosocial interventions enhance HIV medication adherence: A systematic review and meta-analysis. Journal of Health Psychology. 2018;00(0):1-15. DOI: 10.1177/1359105318755545

32. Vysokaja komplaentnost’ kak faktor jeff ektivnogo lechenija arterial’noj gipertonii. Interv’ju s d.m.n., professorom F.T. Ageevym, glavnym nauchnym sotrudnikom otdela ambulatornyh lechebnodiagnosticheskih tehnologij NII kardiologii im. A.L. Mjasnikova FGBU «NMIC kardiologii» Minzdrava Rossii, Moscow. RMJ. 2018;6(1):5-8. (In Russ).

33. Memorandum jekspertov Rossijskogo kardiologicheskogo obshhestva po rekomendacijam Evropejskogo obshhestva kardiologov / Evropejskogo obshhestva po arterial’noj gipertenzii po lecheniju arterial’noj gipertenzii 2018 g. Rossijskij kardiologicheskij zhurnal. 2018;23(12):131-142. (In Russ). DOI: 10.15829/1560-4071-2018-12-131-142

34. Taibanguay N, Chaiamnuay S, Asavatanabodee P, Narongroeknawin P. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial. Patient Preference and Adherence. 2019;13:119-129. DOI:10.2147/PPA.S192008

35. Brixner D, Rubin DT, Mease P, et al. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. Journal of Managed Care & Specialty Pharmacy. 2019;25(7):770-779a.